Stimulation of cytokine production in human peripheral blood mononuclear cells by an aqueous Chlorella extract

Planta Medica

Volumn 73, Issue 8, 2007, Pages 762-768

  Ewart, H Stephen ^a   Bloch, Olga ^b   Girouard, Gabrielle S ^a   Kralovec, Jaroslav ^a   Barrow, Colin J ^a   Ben Yehudah, Gilad ^b   Suárez, Erick Reyes ^c   Rapoport, Micha J ^b  

^a Ocean Nutrition Canada Ltd   (Canada)

^b TEL AVIV UNIVERSITY   (Israel)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Chlorella pyrenoidosa; Chlorellaceae; Human peripheral blood mononuclear cells; Immunostimulation; T helper 1 cells; T helper 2 cells

Indexed keywords

CHLORELLA PYRENOIDOSA EXTRACT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL COUNT; CELL PROLIFERATION; CHLORELLA; CHLORELLA PYRENOIDOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ADULT; CHLORELLA; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PHYTOTHERAPY; PLANT EXTRACTS;

ALGAE; CHLORELLA (CHLORELLALES); CHLORELLA PYRENOIDOSA; CHLORELLACEAE;

EID: 34547763820     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981544     Document Type: Article

References (26)

1. Kessler E. Comparative physiology and biochemistry of Chlorella species as the basis for their taxonomy and for their utilization in research and biotechnology. In: Kumar HD, editor. Phycotalk. Meerut: Rastogi and Co; 1989: 141-53.
2. Merchant RE, Andre CA. Dietary supplementation with Chlorella pyrenoidosa produces positive results in patients with cancer or suffering from certain chronic illnesses. JANA 2001; 4: 31-8.
3. Konishi F, Tanaka K, Kumamoto S, Hasegawa T, Okuda M, Yano I et al. Enhanced resistance against Escherichia coli infection by subcutaneous administration of the hot-water extract of Chlorella vulgaris in cyclophosphamide-treated mice. Cancer Immunol Immunother 1990; 32: 1-7.
4. Miyazawa Y, Murayama T, Ooya N, Wang LF, Tung YC, Yamaguchi M. Immunomodulation by a unicellular green algae (Chlorella pyrenoidosa) in tumor bearing mice. J Ethnopharmacol 1988; 24: 135-46.
5. Tanaka K, Koga T, Konishi F, Nakamura M, Mitsuyama M, Himeno K et al. Augmentation of host defense by a unicellular green alga, Chlorella vulgaris, to Escherichia coli infection. Infect Immun 1986; 53: 267-71.
6. Umezawa I, Komiyama K, Shibukawa N, Mori M, Kojima Y. An acidic polysaccharide, Chlon A from Chlorella pyrenoidosa: 1. Physicochemical and biological properties. Chemotherapy 1982; 30: 1041-6.
7. Hasegawa T, Kimura Y, Hiromatsu K, Kobayashi N, Yamada A, Makino M et al. Effect of hot water extract of Chlorella vulgaris on cytokine expression patterns in mice with murine acquired immunodeficiency syndrome after infection with Listeria monocytogenes. Immunopharmacology 1997;35:273-82.
8. Pugh N, Ross SA, ElSohly NH, ElSohly MA, Pasco DS. Isolation of three molecular weight polysaccharide preparations with potent immunostimulatory activity from Spirulina vulgaris, Aphanizomenon flos-aque and Chlorella pyrenoidosa. Planta Med 2001; 67: 737-42.
9. Hasegawa T, Ito K, Ueno S, Kumamoto S, Ando Y, Yamada A et al. Oral administration of hot water extracts of Chlorella vulgaris reduces IgE production against milk casein in mice. Int J Immunopharmacol 1999; 21: 311-23.
10. Halperin SA, Smith B, Nolan C, Shay J, Kralovec J. Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized,, double-blind, placebo-controlled trial. CMAJ 2003; 169: 111-7.
11. Kralovec JA, Metera K, Kumar JR. Watson LV, Girouard GS, Guan Y et al. Immunostimulatory principles from Chlorella pyrenoidosa - Part 1: Isolation and biological assessment in vitro. Phytomedicine 2007; 14: 57-64.
12. Kralovec JA, Power MR, Liu F, Maydanski E, Ewart HS, Watson LV et al. An aqueous Chlorella extract inhibits IL-5 production by mast cells in vitro and reduces ovalbumin-induced eosinophil infiltration in the airway in mice in vivo. Int Immunopharmacol 2005; 5: 689-98.
13. Reyes Suarez E, Kralovec J, Noseda MD, Ewart HS, Barrow CJ, Lumsden MD et al. Isolation, characterization and structural determination of a unique type of arabinogalactan from a immunostimulatory extract of Chlorella pyrenoidosa. Carbohydr Res 2005; 340: 1489-98.
14. Konishi F, Tanaka K, Himeno K, Taniguchi K, Nomoto K. Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes. Cancer Immunol Immunother 1985; 19: 73-8.
15. Armstrong PB, Armstrong MT, Pardy RL, Child A, Wainwright N. Immunohistochemical demonstration of a lipopolysaccharide in the cell wall of a eukaryote, the green alga, Chlorella. Biol Bull 2002; 203: 203-4.
16. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3: 944-50.
17. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect Immun 2000; 68: 6883-90.
18. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altera Med Rev 2003; 8: 223-46.
19. Goodin DS, Frohman EM, Garmany J, Halper J, Likosky WH, Lublin FD et al. Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002; 58: 169-78.
20. Lipsky PE, van der Heijde DM, Furst DE, Breedveld FC, Kalden JR. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343: 1594-602.
21. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178: 87-99.
22. Hofstetter C, Flondor M, Hoegl S, Muhl H, Zwissler B. Interleukin-10 aerosol reduces proinflammatory mediators in bronchoalveolar fluid of endotoxemic rat. Crit Care Med 2005; 33: 2317-22.
23. Hess PJ, Seeger JM, Huber TS, Welborn MB, Martin TD, Harward TRS et al. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. J Vasc Surg 1997; 26: 113-8.
24. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H et al. IL-10 is a key cytokine in psoriasis . Proof of principle by IL-10 therapy: A new therapeutic approach. J Clin Invest 1998; 101: 783-94.
25. Chabot S, Williams G, Hamilton M, Sutherland G, Yong VW. Mechanisms of IL-10 production in human microglia-T cell interaction. J Immunol 1999; 162: 6819-28.
26. Roon JAG van, Wijngaarden S, Lafeber FPJG, Damen C, van de Winkel JGJ, Bijlsma JWJ. Interleukin 10 treatment of patients with RA enhances Fcg receptor expression on monocytes and responsiveness to immune complex stimulation. J Rheumatol 2003; 30: 648-51.